In a message to shareholders in the company's Annual Report for 2017-18, Sun Pharma managing director Dilip Shanghvi however said the government's enforced price cuts and policy changes are potential risk factors for the business.
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/2NhfeNz
via IFTTT
Tuesday 2 October 2018
Home
/
Business News: Latest News on Business
/
Financial News
/
India Business & World Business News
/
Stock Markets
/
Sun Pharma expects normalisation of India business in FY'19
Sun Pharma expects normalisation of India business in FY'19
About mani
Sora Blogging Tips is a blogger resources site is a provider of high quality blogger template with premium looking layout and robust design. The main mission of sora blogging tips is to provide the best quality blogger templates.
Stock Markets
Labels:
Business News: Latest News on Business,
Financial News,
India Business & World Business News,
Stock Markets
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment